In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Aloperidin Drug Master File in Korea (Aloperidin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Aloperidin. The MFDS reviews the Aloperidin KDMF as part of the drug registration process and uses the information provided in the Aloperidin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Aloperidin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Aloperidin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Aloperidin suppliers with KDMF on PharmaCompass.